ã¡ã³ã¿ã«ãã«ã¹ãã¹ãã¬ã¹ç®¡çãå¿çåŠã®ææ°ç ç©¶ãšæ¥åžžã®ã±ã¢
41
ã¡ã³ããŒ
20
æçš¿
æ³ã®ãããç ããæµ ããªã£ãŠããŠãç¡ç ãšäœã®èåã£ãŠé¢ä¿ããã®ããªãšèããããã«ãªããŸãããå¯äžè¶³ãç¶ããšç¿æ¥ã®èª¿åãæããã«éãã®ã¯å®æããŠããŸãã åãããã«æããŠããæ¹ãäœã工倫ããŠããããšã¯ãããŸãããéè«çšåºŠã§å€§äžå€«ã§ãã
åçå»çãéºäŒåæ²»çã®é²å±ã远ããããã®ã¯å¥œããªã®ã§ãããèªåãå®¶æã«åœãŠã¯ããŠèãå§ãããšãæåŸ ãšåããããäžå®ãæ¹§ããŠããŸãã æ å ±ã远ãããšèªäœã¯ååããªè¡åã®ã¯ããªã®ã«ã远ããããŠèœã¡çããªããªãæããããåããããªæèŠã®æ¹ãã©ãæãåããã€ããŠããŸããã
å¥åº·ãå»çã®æ°ãããã¥ãŒã¹ã远ããããã®ã¯æ¥œãããã§ããããšãã©ãæ å ±ã®éã«æŒãã€ã¶ããããã«ãªããŸããããããããæ°ã«ããã»ããããã®ããªãšèãã ããšãããã£ãŠèœã¡çããªããªã£ãŠããŸã£ãŠã èªåãªãã«ãä¿¡é Œã§ããæ å ±æºãããã€ãã«çµã£ãŠãããšã¯æ°ã«ããããªãããã«ããŠããŸããã¿ãªããã¯æ å ±ãšã®è·é¢ã®åãæ¹ãã©ãããŠããŸããã
æ°ããæ²»çæ³ã®ãã¥ãŒã¹ã¯åžæã«ãªãåé¢ãèªåãå®¶æãããã«åããããããã§ã¯ãªããšåãããšãããã£ãŠèœã¡èŸŒãããšããããŸãã é²è¡äžã®ç æ°ãšåãåããªãããéåºŠã«æåŸ ãããããã§ãåžæã¯å€±ããã«ããããã®ãå¿ã®æã¡ããã¿ãããªãã®ããåãç«å Žã®æ¹ãšããã話ããããšæã£ãŠæžããŸããã
ããæ°ãæãå¯ãæéãã°ãã°ãã§æ¥äžããªããšãªãèœã¡çããªãæ¥ãç¶ããŠããŸãããæãåã£ãŠæ¯æ¥åãæéã«å¯èµ·ãããããã«ããããæ°åã®æµ®ãæ²ã¿ãåããç©ããã«ãªã£ãæ°ãããŸãã äœæãªã®ã§æ°ã®ãããããããŸããããç¡ç ãšæ°æã¡ã®ã€ãªããã¯æã£ã以äžã«å€§ãããã ãªãšå®æããŠããŸããã¿ãªããã®æ°å転æãçæŽ»ãªãºã ã®å·¥å€«ãããã°èããŠã¿ããã§ãã
å®¶æãæ ¢æ§ã®ç æ°ãæ±ããŠããŠãæ¬äººãåšããæ°æã¡ã®æµ®ãæ²ã¿ã倧ããã§ãã æ°ããæ²»çã®ãã¥ãŒã¹ã¯åžæã«ãªãäžæ¹ãããã«èªåãã¡ã«å±ãããã§ã¯ãªãçŸå®ãšã®ã®ã£ããããã£ãŠãåããããªç«å Žã®æ¹ã®å·¥å€«ãããã°èãããã§ãã
æ°ããæ²»çãç ç©¶ã®ãã¥ãŒã¹ã远ãã®ã¯æ¥œããã®ã§ããããšãã©ãæ å ±éã«é£²ãŸããŠæ°æã¡ãèœã¡çããªããªãããšããããŸãã ç¹ã«èªåãå®¶æã®äœèª¿ãæ°ã«ãªã£ãŠããææã¯ãæ€çŽ¢ããã°ããã»ã©äžå®ãå¢ããæªåŸªç°ã«å ¥ããã¡ã§ãããæè¿ã¯ãå€ã¯èª¿ã¹ç©ãããªããšããäžæ¬¡æ å ±ã ãèŠãŠSNSã®åå¿ã¯è¿œããªãããšãã£ãã«ãŒã«ãèªåã«èª²ããŠããŸãã å®ç§ã§ã¯ãªãã§ãããå°ã楜ã«ãªããŸãããã¿ãªããã¯æ å ±ãšã®è·é¢ãã©ãåã£ãŠããŸããã
å人ã®çµéšã§ããå»åŠçãªè©±ã§ã¯ãªãã®ã§åèçšåºŠã«ã å»å¹Žã®ç§ãããæé£åã«20åã ãè¿æãæ©ãç¿æ £ãå§ããŸããã å幎çµã£ãŠæ°ã¥ããã®ã¯ãæ°åã®èœã¡èŸŒã¿ã®ãæ·±ãããæµ ããªã£ãããšã ãŒãã«ã¯ãªããªãããã©ãæ·±ããšãããŸã§æ²ãŸãªããªã£ãæèŠããããŸãã è¬ã飲ãã§ãã人ã«ãšã£ãŠã¯éåã ãã§ååãšã¯èšããªããšæããŸããã äœãã®è¶³ãã«ã¯ãªãæ°ãããŠããŸãã 䌌ããããªçµéšã®ããæ¹ãããã£ããå ±æããŠãã ããã
ãã©ã€ããªã§è»œåºŠãäžç床ã®ãã€ç ã«å¯ŸããŠSSRIãéå§ããã±ãŒã¹ãå¢ããŠããŸããã説ææéã倿¥ã§ååã«ãšããæ©ãã§ããŸãã é¢è±çåçŸ€ãæ§æ©èœé¢é£ãè¥å¹Žå±€ã®èªæ®ºå¿µæ ®å¢å ãªã¹ã¯ââã©ããè«æãèªãã°æžããŠããã®ã§ããããã¹ãŠ15åã§äŒãããšæ£è ãããèçž®ããŠæè¬ããªããªãããšããããŸãã ååã§ãã¹ãŠäŒããæŽŸãšãå¯äœçšãåºãŠããéæèª¬æããæŽŸãšåããããã§ãããçããã¯ã©ãéçšãããŠããŸããã
é©å¿é害ã§äŒè·äžã埩è·ã«åããŠãªã¯ãŒã¯ãæ€èšããŠããŸããå»çæ©é¢äœµèšåãå°åæ¯æŽåãäŒæ¥åãåãšçš®é¡ãããã€ãããã®ã¯åãã£ãã®ã§ãããã©ããèªåã«åããã®å€æè»žãèŠããŸããã éã£ãæ¹ã¯ãäœãåºæºã«éžã³ãŸããããæéãéæé »åºŠãã°ã«ãŒãã®èŠæš¡ãæéã埩è·çââã©ããäžçªèŠãããæããŠãããããšå©ãããŸãã
å¥ã®æ¹ã®çæ³ã¢ããªã®èšäºãèªãã§ãèªåãèšé²ãã€ããªãã90æ¥ç¶ããŠã¿ãã®ã§ãã§ããã ã䞻芳ãå ¥ããã«å€åãæ®ããŸãã 䜿ã£ãã®ã¯10åã®ã¬ã€ãä»ãé³å£°ãæèµ·ããŠãããç¶ç¶çã¯82æ¥/90æ¥ã å€åãšããŠæž¬ããã®ã¯ãApple Watchã®å€éå¹³åå¿æã58â54ãå ¥ç ãŸã§(å¯å®€ã«å ¥ã£ãŠããç ããŸã§)ã®èªå·±ç³åå¹³åã28åâ17åãMood meterã®èšé²ã§ãäžå®ããéžãã æ¥ã62%â34%ã§ããã ãã¡ããn=1ã§ããã®ææã«ä»äºã®ç¹å¿æãæãããšãã亀絡ããããŸããããã§ãããªããšãªãã®ã楜ã«ãªã£ããã§ã¯ãªãæ°åã«æ®ãããšããã¯æ®ããããšããã®ãå人çãªçºèŠã§ããã
äœåºŠãçæ³ã¢ããªãå§ããŠã¯æ«æããŠããŸããæåã®äžé±éã¯ããæ°ãåºãã®ã§ãããã ãã ãéããªããªã£ãŠããŸããç¶ããŠããæ¹ã¯ã©ããªå·¥å€«ãããŠããã®ãç¥ãããã§ããæé垯ãåºå®ãããšããããšãã話ãèããŸããã
èšåºå¿ç士ãšããŠåããŠããŸãã çžè«ã«æ¥ãããæ¹ã®è©±ãèããŠãããšã調åã厩ãããšãã¯ãããŠãç¡ç ãå ã«ä¹±ããŠããããšãå€ãã§ããç§èªèº«ããå¿ããææã»ã©ç¡ç æéãåããã¡ã§ãåŸããæ°åã®èœã¡èŸŒã¿ãšããŠè¿ã£ãŠããã®ã宿ããŠããŸãã ç¡ç ãæåªå ã«å®ãããšããã ãã§ãçµæ§éããšæããŠããŸãã
ããå幎ã»ã©ä»äºã®ãã¬ãã·ã£ãŒããã€ããŠãæããã£ãŠã«ãŠã³ã»ãªã³ã°ã«è¡ã£ãŠã¿ãŸããã è¡ãåã¯ãèªåãè¡ããããªãšãããããªãããšåæã«æã£ãŠããŸããããè©±ãæŽçããŠèšèã«ããã ãã§ãããªã楜ã«ãªããŸããã åãããã«è¿·ã£ãŠãã人ãããããããŒãã«ã¯ãããªã«é«ããªããããšäŒããããŠæžããŸããã
Johns Hopkinså ¬è¡è¡ç倧åŠé¢ã2025幎ã®å ¬è¡ä¿å¥ãæ¯ãè¿ãèšäºãå ¬éãã粟ç¥ä¿å¥ãµãŒãã¹ãžã®ã¢ã¯ã»ã¹æ¹åãæå€§ã®å€åãšããŠæããããŸãããããã«ç¶ããAPAïŒç±³åœå¿çåŠäŒïŒã2026å¹Žã®æ°æ¿çãçºè¡šããŠããŸãã APAã®äž»èŠæ¿çïŒ ã»Mental Health Parityæ³ã®å·è¡åŒ·å â ä¿éºäŒç€Ÿã«ãã粟ç¥ç§å蚺ã®å¶éã峿 Œã«èŠå¶ ã»é é粟ç¥å»çã®æä¹ å â COVIDæéäžã®äžææªçœ®ãæ£åŒã«å¶åºŠå ã»988 Suicide & Crisis LifelineïŒèªæ®ºäºé²ãããã©ã€ã³ïŒã®å€èšèªå¯Ÿå¿æ¡å ã»åŠæ ¡ããŒã¹ã®ã¡ã³ã¿ã«ãã«ã¹ãµãŒãã¹æ¡å€§ãžã®é£éŠè£å©é 粟ç¥ç§å»ãšããŠã®èå¯ïŒ æ¥æ¬ãšã®æ¯èŒã§ç¹ã«å°è±¡çãªã®ã¯ãParityæ³ã®å·è¡åŒ·åãã§ããæ¥æ¬ã§ã¯ç²Ÿç¥ç§ãšä»ç§ã®ä¿éºç¹æ°æ Œå·®ãäŸç¶ãšããŠå€§ããã粟ç¥ç§å»ã®åŸ éæ¹åãªãããŠã¢ã¯ã»ã¹æ¹åã¯ããããªããšæããŠããŸãã äžæ¹ãé é粟ç¥å»çã«ã€ããŠã¯æ¥æ¬ã§ã2024幎以éã®èŠå¶ç·©åã§é²å±ãèŠãããŸãããã ãå蚺ããã®ãªã³ã©ã€ã³èšºçã«ã€ããŠã¯è³åŠäž¡è«ãã¿ãªããã®çŸå Žã§ã¯ã©ãã§ããïŒ ç¹ã«å°æ¹åšäœã®æ¹ã粟ç¥ç§ãžã®ã¢ã¯ã»ã¹ã«ã€ããŠæããŠããããšãããã°ãã²å ±æããŠãã ããã
Navigating the latest mental health parity rules: Preparing for 2025 and 2026
Thoughts for health plans and plan sponsors on navigating the latest mental health parity rules that take effect in 2025 and 2026.
www.milliman.com
å é±éå¬ãããFDAè«®åå§å¡äŒïŒPDACïŒã§ã®ã·ãã·ãã³è£å©çæ³ïŒæ²»çæµææ§ãã€ç é©å¿ïŒã®è°è«ãæŽçããŸããã粟ç¥ç§å»ãšããŠéåžžã«æ³šç®ããŠããŸãã â è¯å®çã«è©äŸ¡ãããç¹ ã»COMP360詊éšïŒ25mg矀ã§MADRSæ¹åã-12.0ãã€ã³ãïŒãã©ã»ãæ¯ïŒ ã»æ²»çæµææ§ãã€ç ãšãã飿²»é åã§ã®æ°éžæè¢ ã»äœçšæ©åºãSSRI/SNRIãšæ ¹æ¬çã«ç°ãªãïŒ5-HT2AäœåïŒç¥çµå¯å¡æ§ä¿é²ïŒ ã»1-2åã®æäžã§æ°é±éïœæ°ã¶æã®å¹ææç¶ â æžå¿µã瀺ãããç¹ ã»ãã»ããïŒã»ããã£ã³ã°ãã®æšæºåãå°é£ ã»æ²»çã»ãã·ã§ã³äžã®ã»ã©ãã¹ã-æ£è é¢ä¿ã®å¢çèšå® ã»é·æå®å šæ§ããŒã¿ãäžååïŒæé·è¿œè·¡ã¯12ã¶æïŒ ã»ä¹±çšãªã¹ã¯ã®ç®¡çäœå¶ïŒSchedule Iç©è³ªïŒ ã»REMSïŒãªã¹ã¯è©äŸ¡ã»è»œæžæŠç¥ïŒã®å ·äœçãªå®æœæ¹æ³ â å人çèŠè§£ 粟ç¥ç§èšåºã§æ²»çæµææ§ãã€ç ã®æ£è ãããå€ã蚺ãŠããŸãããæ¢åæ²»çã§ååãªå¹æãåŸãããªãã±ãŒã¹ã¯æ¬åœã«å€ããã·ãã·ãã³çæ³ã¯ãéã®åŒŸäžžãã§ã¯ãªãã§ãããéžæè¢ãå¢ããããšèªäœã«å€§ããªæçŸ©ããããšèããŸãã ãã ããæ¥æ¬ã§ã®å®çšåã«ã¯ãŸã ããŒãã«ãé«ãããŸãã¯ç±³åœã§ã®æ¿èªããã»ã¹ã泚èŠãã€ã€ãæ¥æ¬ã®èŠå¶ç°å¢ã«åãããè°è«ãå§ããææã ãšæããŸãã çããã®èŠè§£ããã²èãããŠãã ããã
è žè³çžé¢ã«é¢ããææ°ã®ã¡ã¿ã¢ããªã·ã¹ãç¹å®ã®è žå 现èçš®ãšãã€ç ãªã¹ã¯ã®é¢é£ãçµ±èšçã«ææãšå ±åãããŠããŸãããããã€ãªãã£ã¯ã¹ã®ä»å ¥ç ç©¶ãå¢ããŠããŸãããããŸã èšåºçãªãšããã³ã¹ã¬ãã«ãšããŠã¯äžååã粟ç¥ç§ãšæ¶ååšç§ã®é£æºãä»åŸéèŠã«ãªãããã§ãã
pubmed.ncbi.nlm.nih.gov
èšåºå¿ç士ãšããŠããã€ã³ããã«ãã¹çæ³ã®ãšããã³ã¹ãæŽçããŸãããäžå®é害ããã€ç ã®åçºäºé²ã«ã¯äžå®ã®ãšããã³ã¹ããããã ããPTSDãé床ã®ãã€ã«ã¯åç¬ã§ã¯äžååããäžèœè¬ãã§ã¯ãªãããšãæ£ããçè§£ããäžã§æŽ»çšããããšãéèŠã§ãã
ãã³ãããã¯åŸãå»çåŸäºè ã®ããŒã³ã¢ãŠãã¯æ·±å»ã§ããåœé¢ã§ã®ã¢ã³ã±ãŒã調æ»ã§ã¯ãçŽ40%ãããŒã³ã¢ãŠãã®å åãç¹ã«ææ¥ç§ãICUã粟ç¥ç§ã§ãªã¹ã¯ãé«ããçµç¹ã¬ãã«ã§ã®å¯ŸçïŒå€åæé管çããã¢ãµããŒãïŒãäžå¯æ¬ ã§ãããå人ã¬ãã«ã®ã»ã«ãã±ã¢ãéèŠã§ãã
è žå 现èå¢ãšãã€ç ã®å æé¢ä¿ãNatureã§å ±åãããŸãããèšåºçŸå Žã§ã®æŽ»çšã¯ãŸã å ã§ããã粟ç¥ç§ãšæ¶ååšç§ã®é£æºãéèŠã«ãªã£ãŠãããããããŸããã
ãã¹ãŠè¡šç€ºããŸãã